(Q39817880)

14 September 2017

title

Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location (English)

1 reference

14 September 2017

1 reference

Yu-Ching Wei

1

1 reference

14 September 2017

Chien-Feng Li

2

1 reference

14 September 2017

Shih-Chen Yu

3

1 reference

14 September 2017

Fong-Fu Chou

4

1 reference

14 September 2017

Fu-Min Fang

5

1 reference

14 September 2017

Hock-Liew Eng

6

1 reference

14 September 2017

Yih-Huei Uen

7

1 reference

14 September 2017

Yu-Fang Tian

8

1 reference

14 September 2017

Jing-Mei Wu

9

1 reference

14 September 2017

Shau-Hsuan Li

10

1 reference

14 September 2017

Wen-Wei Huang

11

1 reference

14 September 2017

Wei-Ming Li

12

1 reference

14 September 2017

Hsuan-Ying Huang

13

1 reference

14 September 2017

publication date

31 July 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

22

1 reference

14 September 2017

issue

10

1 reference

14 September 2017

page(s)

1351-1360

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.107

14 September 2017

exact match

0 references

cites work

Gastrointestinal stromal tumor: 5 years later

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Biology of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

ERM proteins and merlin: integrators at the cell cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin, a key component in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

The role of the CD44/ezrin complex in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin is a cyclic AMP-dependent protein kinase anchoring protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Molecular targets for tumour progression in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Merlin and ERM proteins: unappreciated roles in cancer development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

The signaling and biological implications of FAK overexpression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Ezrin mediates growth and survival in Ewing’s sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

7 January 2021

A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

7 January 2021

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

7 January 2021

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.107

7 January 2021

10.1038/MODPATHOL.2009.107

Identifiers

DOI

1 reference

14 September 2017

1 reference